Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADSVF-Enriched Fat Micrografts for Hand Manifestations in Systemic Sclerosis
NCT04387825Phase 2Completed
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Aug 2015
- Primary completion
- May 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous adipose stromal vascular fraction in systemic sclerosis (SSc) (2 arms), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Primary endpoints: Pain Assessment, Frequency of Raynaud Phenomenon up to 168 days and 1 more. Started Aug 2015; status: completed.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT04387825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04387825.